No IL-18BP? Avoid HAV.

Area of Science:

• Immunology
• Hepatology
• Genetics

Background:

• Fulminant viral hepatitis is a rare but severe outcome of viral infection.
• The underlying genetic or molecular basis for this extreme phenotype has been largely unknown.
• Understanding the mechanisms is crucial for potential therapeutic targets.

Purpose of the Study:

• To investigate the genetic basis of fulminant viral hepatitis in a severely affected patient.
• To elucidate the molecular mechanisms linking genetic defects to severe liver injury.
• To identify the role of specific immune cells in the pathogenesis.

Main Methods:

• Whole exome sequencing to identify genetic variations.
• In vitro assays to assess immune cell function.
• Analysis of cytokine signaling pathways.

Main Results:

• A novel deletion in the Interleukin-18 Binding Protein (IL18BP) gene was identified.
• This deletion resulted in excessive activation of natural killer (NK) cells.
• Uncontrolled NK cell activity led to the destruction of hepatocytes (liver cells).

Conclusions:

• A specific IL18BP gene deletion is a cause of fulminant viral hepatitis.
• Dysregulated NK cell immunity, driven by IL18BP deficiency, underlies severe liver damage.
• This discovery opens new avenues for understanding and potentially treating severe viral hepatitis.